{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:23:53Z","timestamp":1778682233856,"version":"3.51.4"},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"1 Pt 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1957,1,1]]},"DOI":"10.1172\/jci103412","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T14:36:14Z","timestamp":1202913374000},"page":"74-80","source":"Crossref","is-referenced-by-count":24,"title":["The Effect of Glucagon on the Blood Glucose Level and the Clinical State in the Presence of Marked Insulin Hypoglycemia  12"],"prefix":"10.1172","volume":"36","author":[{"given":"Jerome L.","family":"Schulman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley E.","family":"Greben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/103412\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:55:07Z","timestamp":1691081707000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/103412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1957,1,1]]},"references-count":0,"journal-issue":{"issue":"1 Pt 1","published-print":{"date-parts":[[1957,1,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci103412","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1957,1,1]]}}}